The Florida Department of Health notified the FDA of a cluster of streptococcus endophthalmitis infections in three clinics, following intravitreal injection of the repackaged Avastin.
The tainted injections were traced to a pharmacy in Hollywood, Fla.
Related Articles on FDA Alerts:
FDA Warns Healthcare Professionals to Stop Using Claris IV Bags
Hospira Expands Recall of Propofol and Liposyn
Commentary on Safety Concerns Regarding Fresenius Propofol From Anesthesiologist Daniel Van Riper
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.